Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Immunoglobulins, Intravenous"" wg kryterium: Temat


Tytuł :
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
Autorzy :
Aggarwal R; University of Pittsburgh School of Medicine, Pittsburgh, PA.
Charles-Schoeman C; University of California, Los Angeles, CA.
Schessl J; Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians University of Munich, Munich, Germany.
Dimachkie MM; University of Kansas Medical Center, Kansas City, KS.
Beckmann I; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.
Levine T; Department of Neurology, Phoenix Neurological Associates, Ltd., Phoenix, AZ.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jan 08; Vol. 100 (1), pp. e23677.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Dermatomyositis/*drug therapy
Immunoglobulins, Intravenous/*standards
Adult ; Double-Blind Method ; Female ; Humans ; Immunoglobulins, Intravenous/pharmacology ; Immunoglobulins, Intravenous/therapeutic use ; Male ; Middle Aged ; Placebos ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children.
Autorzy :
Belhadjer Z; M3C-Necker Enfants malades, AP-HP, Paris, France (Z.B., J.A., M.M., L.H., D.B.).; Université de Paris, France (Z.B., J.A., M.O., S.R., L.H., D.B.).
Auriau J; M3C-Necker Enfants malades, AP-HP, Paris, France (Z.B., J.A., M.M., L.H., D.B.).; Université de Paris, France (Z.B., J.A., M.O., S.R., L.H., D.B.).
Méot M; M3C-Necker Enfants malades, AP-HP, Paris, France (Z.B., J.A., M.M., L.H., D.B.).
Oualha M; Université de Paris, France (Z.B., J.A., M.O., S.R., L.H., D.B.).; Pediatric Intensive Care Unit, Necker Enfants Malades, AP-HP, Paris, France (M.O., S.R.).
Renolleau S; Université de Paris, France (Z.B., J.A., M.O., S.R., L.H., D.B.).; Pediatric Intensive Care Unit, Necker Enfants Malades, AP-HP, Paris, France (M.O., S.R.).
Houyel L; M3C-Necker Enfants malades, AP-HP, Paris, France (Z.B., J.A., M.M., L.H., D.B.).; Université de Paris, France (Z.B., J.A., M.O., S.R., L.H., D.B.).
Bonnet D; Université de Paris, France (Z.B., J.A., M.O., S.R., L.H., D.B.).; UMR-1163 INSERM, Institut IMAGINE, IcarP Cardiology, Paris, France (D.B.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2020 Dec 08; Vol. 142 (23), pp. 2282-2284. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :
Letter
MeSH Terms :
Adrenal Cortex Hormones/*therapeutic use
COVID-19/*drug therapy
Cardiovascular Diseases/*drug therapy
Immunoglobulins, Intravenous/*therapeutic use
Immunologic Factors/*therapeutic use
Systemic Inflammatory Response Syndrome/*drug therapy
Adrenal Cortex Hormones/pharmacology ; Cardiovascular Diseases/etiology ; Child ; Female ; Humans ; Immunoglobulins, Intravenous/pharmacology ; Immunologic Factors/pharmacology ; Male ; Treatment Outcome
SCR Disease Name :
pediatric multisystem inflammatory disease, COVID-19 related
Opinia redakcyjna
Tytuł :
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Autorzy :
Ali S; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan. .
Luxmi S; Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.
Anjum F; Dow Research Institute of Biotechnology and Biomedical Sciences, Dow University of Health Sciences, Karachi, Pakistan.
Muhaymin SM; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Uddin SM; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Ali A; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Ali MR; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Tauheed S; Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Khan M; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Bajwa M; Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.
Baig SU; Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.
Shalim E; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Ahmed I; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Khan AS; National Control Laboratory for Biologicals, Islamabad, Pakistan.
Quraishy S; Dow University of Health Sciences, Karachi, Pakistan.
Pokaż więcej
Źródło :
Trials [Trials] 2020 Nov 02; Vol. 21 (1), pp. 905. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Clinical Trial Protocol; Letter
MeSH Terms :
Immunoglobulins, Intravenous*/administration & dosage
Immunoglobulins, Intravenous*/adverse effects
Coronavirus Infections/*therapy
Immunization, Passive/*methods
Pneumonia, Viral/*therapy
Adult ; Betacoronavirus/isolation & purification ; COVID-19 ; Critical Illness/therapy ; Female ; Humans ; Immunologic Factors/administration & dosage ; Immunologic Factors/adverse effects ; Male ; Pandemics ; Randomized Controlled Trials as Topic ; SARS-CoV-2 ; Severity of Illness Index ; Treatment Outcome
SCR Protocol :
COVID-19 serotherapy
Opinia redakcyjna
Tytuł :
Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.
Autorzy :
Perraudin C; Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Bourdin A; Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Vicino A; Nerve-Muscle Unit, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Kuntzer T; Nerve-Muscle Unit, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Bugnon O; Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland.
Berger J; Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 25; Vol. 15 (11), pp. e0242630. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Home Care Services/*economics
Immunoglobulins, Intravenous/*economics
Medication Therapy Management/*economics
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/*economics
Cost-Benefit Analysis ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Infusions, Subcutaneous ; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/drug therapy ; Switzerland
Czasopismo naukowe
Tytuł :
The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
Autorzy :
Kanai T; Department of Pediatrics, National Defense Medical College, Namiki 3-2, Tokorozawa, Saitama, 359-8513, Japan. .
Takeshita S; Division of Nursing, School of Medicine, National Defense Medical College, Tokorozawa, Japan.
Kawamura Y; Department of Pediatrics, National Defense Medical College, Namiki 3-2, Tokorozawa, Saitama, 359-8513, Japan.
Kinoshita K; Department of Pediatrics, Koshigaya Municipal Hospital, Koshigaya, Japan.
Nakatani K; Department of Pediatrics, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.
Iwashima S; Department of Pediatric Cardiology, Chutoen General Medical Center, Kakegawa, Japan.
Takizawa Y; Department of Pediatrics, National Hospital Organization, Nishisaitama-Chuo National Hospital, Tokorozawa, Japan.
Hirono K; Department of Pediatrics, Graduate School of Medicine, University of Toyama, Toyama, Japan.
Mori K; Department of Pediatrics, Seirei Sakura Citizen Hospital, Sakura, Japan.
Yoshida Y; Department of Pediatrics, National Defense Medical College, Namiki 3-2, Tokorozawa, Saitama, 359-8513, Japan.
Nonoyama S; Department of Pediatrics, National Defense Medical College, Namiki 3-2, Tokorozawa, Saitama, 359-8513, Japan.
Pokaż więcej
Źródło :
Heart and vessels [Heart Vessels] 2020 Oct; Vol. 35 (10), pp. 1463-1472. Date of Electronic Publication: 2020 May 24.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Blood Platelets*
Drug Resistance*
Lymphocytes*
Neutrophils*
Immunoglobulins, Intravenous/*administration & dosage
Immunologic Factors/*administration & dosage
Mucocutaneous Lymph Node Syndrome/*drug therapy
Child ; Child, Preschool ; Female ; Humans ; Immunoglobulins, Intravenous/adverse effects ; Immunologic Factors/adverse effects ; Infant ; Japan ; Lymphocyte Count ; Male ; Mucocutaneous Lymph Node Syndrome/blood ; Mucocutaneous Lymph Node Syndrome/diagnosis ; Platelet Count ; Predictive Value of Tests ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
Autorzy :
Morabito CJ; Millennium Pharmaceuticals, Inc, a Takeda company, Cambridge, Massachusetts, USA.
Gangadharan B; Baxalta Innovations GmbH, a Takeda company, Vienna, Austria.
Pokaż więcej
Źródło :
Clinical and translational science [Clin Transl Sci] 2020 Sep; Vol. 13 (5), pp. 835-837. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Viral/*therapeutic use
Betacoronavirus/*immunology
Coronavirus Infections/*therapy
Immunoglobulins, Intravenous/*administration & dosage
Pneumonia, Viral/*therapy
Antibodies, Viral/adverse effects ; Antibodies, Viral/immunology ; COVID-19 ; Clinical Trials as Topic ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Coronavirus Infections/virology ; Humans ; Immunization, Passive/adverse effects ; Immunization, Passive/methods ; Immunoglobulins, Intravenous/adverse effects ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/immunology ; Treatment Outcome
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.
Autorzy :
Arnold DM; Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada; Canadian Blood Services, Ancaster, ON, Canada. Electronic address: .
Heddle NM; Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Cook RJ; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada.
Hsia C; Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada.
Blostein M; Department of Medicine, McGill University, Montreal, QC, Canada.
Jamula E; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Sholzberg M; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Lin Y; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Kassis J; Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Larratt L; Division of Hematology, University of Alberta, Edmonton, AB, Canada.
Tinmouth A; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Amini S; Department of Hematology, HagaZiekenhuis, The Hague, Netherlands.
Schipperus M; Department of Hematology, HagaZiekenhuis, The Hague, Netherlands; Department of Hematology, University Medical Centre Groningen, Groningen, Netherlands.
Lim W; Department of Medicine, McMaster University, Hamilton, ON, Canada.
Vishnu P; Division of Hematology, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Warner M; McGill University Health Centre, Montreal, QC, Canada.
Carruthers J; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Li N; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Lane S; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Kelton JG; Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Pokaż więcej
Źródło :
The Lancet. Haematology [Lancet Haematol] 2020 Sep; Vol. 7 (9), pp. e640-e648.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Benzoates/*therapeutic use
Hydrazines/*therapeutic use
Immunoglobulins, Intravenous/*therapeutic use
Pyrazoles/*therapeutic use
Thrombocytopenia/*drug therapy
Administration, Oral ; Adult ; Aged ; Atrial Fibrillation/etiology ; Benzoates/adverse effects ; Female ; Humans ; Hydrazines/adverse effects ; Immunoglobulins, Intravenous/adverse effects ; Male ; Middle Aged ; Pancreatitis/etiology ; Perioperative Care ; Platelet Count ; Pulmonary Embolism/etiology ; Pyrazoles/adverse effects ; Treatment Outcome ; Vertigo/etiology
Czasopismo naukowe
Tytuł :
Thrombotic risks from pulling the "trigger" on intravenous immunoglobulin and plasma exchange.
Autorzy :
Caress JB; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Yang C; Department of Epidemiology and Health Promotion, College of Dentistry, New York University, New York, New York.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2020 Sep; Vol. 62 (3), pp. 295-296. Date of Electronic Publication: 2020 Jul 04.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Immunoglobulins, Intravenous*
Plasma Exchange*
Cross-Over Studies ; Humans ; Inpatients ; Plasmapheresis
Opinia redakcyjna
Tytuł :
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects.
Autorzy :
Sharun K; Division of Surgery, ICAR-Indian Veterinary Research Institute , Izatnagar, Uttar Pradesh, India.
Tiwari R; Department of Veterinary Microbiology and Immunology, College Of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU) , Mathura, Uttar Pradesh, India.
Iqbal Yatoo M; Division of Veterinary Clinical Complex, Faculty of Veterinary Sciences and Animal Husbandry, Shuhama, Alusteng Srinagar, Sher-E-Kashmir University of Agricultural Sciences and Technology of Kashmir , Srinagar, Jammu and Kashmir, India.
Patel SK; Division of Pathology, ICAR-Indian Veterinary Research Institute , Izatnagar, Uttar Pradesh, India.
Natesan S; Department of Infectious Diseases, Indian Institute of Public Health Gandhinagar , Gandhinagar, Gujarat, India.
Dhama J; Department of Ophthalmology, Tara Hospital , New Delhi, India.
Malik YS; Division of Biological Standardization, ICAR-Indian Veterinary Research Institute , Izatnagar, Uttar Pradesh, India.
Harapan H; Medical Research Unit, School of Medicine, Universitas Syiah Kuala , Banda Aceh, Indonesia.; Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala , Banda Aceh, Indonesia.; Department of Microbiology, School of Medicine, Universitas Syiah Kuala , Banda Aceh, Indonesia.
Singh RK; Division of Veterinary Biotechnology, ICAR-Indian Veterinary Research Institute , Izatnagar, Uttar Pradesh, India.
Dhama K; Division of Pathology, ICAR-Indian Veterinary Research Institute , Izatnagar, Uttar Pradesh, India.
Pokaż więcej
Źródło :
Expert opinion on biological therapy [Expert Opin Biol Ther] 2020 Sep; Vol. 20 (9), pp. 1033-1046. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Betacoronavirus*
Immunoglobulins, Intravenous/*therapeutic use
Immunotherapy/*methods
Antibodies, Neutralizing/therapeutic use ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/immunology ; Coronavirus Infections/therapy ; Humans ; Immunization, Passive ; Immunoglobulins, Intravenous/immunology ; Immunotherapy/trends ; Pandemics/prevention & control ; Pneumonia, Viral/blood ; Pneumonia, Viral/immunology ; Pneumonia, Viral/therapy ; SARS-CoV-2
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.
Autorzy :
Mohtadi N; School of Medicine, Shahid Mostafa Khomaeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Ghaysouri A; Department of Internal Medicine, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Shirazi S; Department of Cardiology, School of Medicine, Shahid Mostafa Khomaeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Sara Ansari; Department of Radiology, School of Medicine, Shahid Mostafa Khomaeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Shafiee E; Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Bastani E; Department of Internal Medicine, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Kokhazadeh T; Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Tavan H; Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran. Electronic address: .
Pokaż więcej
Źródło :
Virology [Virology] 2020 Sep; Vol. 548, pp. 1-5. Date of Electronic Publication: 2020 May 25.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Betacoronavirus*
Coronavirus Infections/*therapy
Immunoglobulins, Intravenous/*therapeutic use
Pneumonia, Viral/*therapy
Aged ; COVID-19 ; Coronavirus Infections/drug therapy ; Disease Progression ; Female ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2 ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report.
Autorzy :
Yanagihashi M; Division of Neurology, Toho University Omori Faculty of Medicine, 6-11-1, Omorinishi, Ota-ku, Tokyo, 143-8541, Japan. .
Okamoto R; Division of Neurology, Toho University Omori Faculty of Medicine, 6-11-1, Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.
Morioka H; Division of Neurology, Toho University Omori Faculty of Medicine, 6-11-1, Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.
Sawada M; Division of Neurology, Toho University Omori Faculty of Medicine, 6-11-1, Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.
Matsumoto S; Division of Cardiovascular Medicine, Toho University Omori Faculty of Medicine, Tokyo, Japan.
Ikeda T; Division of Cardiovascular Medicine, Toho University Omori Faculty of Medicine, Tokyo, Japan.
Kano O; Division of Neurology, Toho University Omori Faculty of Medicine, 6-11-1, Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.
Pokaż więcej
Źródło :
BMC neurology [BMC Neurol] 2020 Aug 28; Vol. 20 (1), pp. 319. Date of Electronic Publication: 2020 Aug 28.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Coronary Vasospasm/*etiology
Immunoglobulins, Intravenous/*adverse effects
Myasthenia Gravis/*drug therapy
Aged, 80 and over ; Antibodies/blood ; Electrocardiography ; Female ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Immunosuppressive Agents/administration & dosage ; Myasthenia Gravis/immunology ; Prednisolone/administration & dosage ; Pyridostigmine Bromide/administration & dosage ; Receptors, Nicotinic/immunology
Czasopismo naukowe
Tytuł :
A machine learning approach to predict intravenous immunoglobulin resistance in Kawasaki disease patients: A study based on a Southeast China population.
Autorzy :
Wang T; Department of pediatrics, Fujian Provincial Maternity and Children's Hospital, Fuzhou, Fujian, China.
Liu G; Department of pediatrics, Fujian Provincial Maternity and Children's Hospital, Fuzhou, Fujian, China.
Lin H; StarCore Co. Ltd., Fuzhou, Fujian, China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Aug 27; Vol. 15 (8), pp. e0237321. Date of Electronic Publication: 2020 Aug 27 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Drug Resistance*
Machine Learning*
Models, Biological*
Immunoglobulins, Intravenous/*pharmacology
Mucocutaneous Lymph Node Syndrome/*drug therapy
Child, Preschool ; China ; Coronary Artery Disease/immunology ; Coronary Artery Disease/prevention & control ; Feasibility Studies ; Female ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Infant ; Logistic Models ; Male ; Mucocutaneous Lymph Node Syndrome/complications ; Mucocutaneous Lymph Node Syndrome/immunology ; ROC Curve ; Retrospective Studies ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
Autorzy :
Ramakrishna C; Department of Molecular Immunology, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Mendonca S; Department of Molecular Immunology, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Ruegger PM; Department of Microbiology and Plant Pathology, University of California, Riverside, California, United States of America.
Kim JH; Department of Microbiology and Plant Pathology, University of California, Riverside, California, United States of America.
Borneman J; Department of Microbiology and Plant Pathology, University of California, Riverside, California, United States of America.
Cantin EM; Department of Molecular Immunology, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Aug 06; Vol. 15 (8), pp. e0237189. Date of Electronic Publication: 2020 Aug 06 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Acyclovir/*adverse effects
Antiviral Agents/*adverse effects
Dysbiosis/*etiology
Herpes Simplex/*microbiology
Immunoglobulins, Intravenous/*adverse effects
Acyclovir/therapeutic use ; Animals ; Antiviral Agents/therapeutic use ; Bacteroidetes/pathogenicity ; Clostridium/pathogenicity ; Dysbiosis/microbiology ; Female ; Gastrointestinal Microbiome ; Herpes Simplex/drug therapy ; Immunoglobulins, Intravenous/therapeutic use ; Male ; Mice ; Mice, Inbred C57BL ; Sex Factors
Czasopismo naukowe
Tytuł :
Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
Autorzy :
Wienzek-Lischka S; Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Langhansstr. 7, 35392, Giessen, Germany. .; German Center for feto-maternal Incompatibility, 35392, Giessen, Germany. .
Sawazki A; Department of Obstectrics/Gynaecology, Justus-Liebig-University Giessen, 35392, Giessen, Germany.
Ehrhardt H; Department of General Pediatrics and Neonatology, Justus-Liebig-University Giessen, 35392, Giessen, Germany.; German Center for feto-maternal Incompatibility, 35392, Giessen, Germany.
Sachs UJ; Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Langhansstr. 7, 35392, Giessen, Germany.; German Center for feto-maternal Incompatibility, 35392, Giessen, Germany.
Axt-Fliedner R; Department of Obstectrics/Gynaecology, Justus-Liebig-University Giessen, 35392, Giessen, Germany.; German Center for feto-maternal Incompatibility, 35392, Giessen, Germany.
Bein G; Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Langhansstr. 7, 35392, Giessen, Germany.; German Center for feto-maternal Incompatibility, 35392, Giessen, Germany.
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Aug; Vol. 302 (2), pp. 355-363. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Journal Article
MeSH Terms :
Hemorrhage/*prevention & control
Immunoglobulins, Intravenous/*administration & dosage
Risk Assessment/*methods
Thrombocytopenia, Neonatal Alloimmune/*prevention & control
Blood Transfusion, Intrauterine ; Female ; Fetal Diseases/diagnosis ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Infant, Newborn ; Platelet Count ; Pregnancy ; Prenatal Care/methods ; Retrospective Studies ; Thrombocytopenia, Neonatal Alloimmune/diagnosis ; Thrombocytopenia, Neonatal Alloimmune/therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Alternative management of Covid-19 infection.
Autorzy :
Atrah HI; Retired Consultant Haematologist (No Hospital Affiliation at Present).
Pokaż więcej
Źródło :
Scottish medical journal [Scott Med J] 2020 Aug; Vol. 65 (3), pp. 72-75. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Journal Article
MeSH Terms :
Betacoronavirus*
Coronavirus Infections/*drug therapy
Immunoglobulins, Intravenous/*therapeutic use
Immunologic Factors/*therapeutic use
Pneumonia, Viral/*drug therapy
Rituximab/*therapeutic use
Thalidomide/*therapeutic use
Administration, Intravenous ; COVID-19 ; Coronavirus Infections/complications ; Cytokine Release Syndrome/drug therapy ; Cytokine Release Syndrome/etiology ; Drug Therapy, Combination/methods ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Immunologic Factors/administration & dosage ; Pandemics ; Pneumonia, Viral/complications ; Rituximab/administration & dosage ; SARS-CoV-2 ; Thalidomide/administration & dosage
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
Autorzy :
Liu X; Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China.
Cao W; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Li T; Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China.; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2020 Jul 14; Vol. 11, pp. 1660. Date of Electronic Publication: 2020 Jul 14 (Print Publication: 2020).
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antibodies, Neutralizing/*therapeutic use
Betacoronavirus/*immunology
Coronavirus Infections/*drug therapy
Coronavirus Infections/*immunology
Immunoglobulin G/*therapeutic use
Immunoglobulins, Intravenous/*therapeutic use
Immunologic Factors/*therapeutic use
Pneumonia, Viral/*drug therapy
Pneumonia, Viral/*immunology
Adult ; Animals ; Antibodies, Neutralizing/administration & dosage ; Antibody-Dependent Enhancement ; COVID-19 ; Child ; Coronavirus Infections/virology ; Cytokines/metabolism ; Humans ; Immunoglobulin Fab Fragments/metabolism ; Immunoglobulin Fc Fragments/metabolism ; Immunoglobulin G/administration & dosage ; Immunoglobulins, Intravenous/administration & dosage ; Immunologic Factors/administration & dosage ; Pandemics ; Pneumonia, Viral/virology ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
[European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology].
Autorzy :
Hadaschik E; Hautklinik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland.
Eming R; Klinik für Dermatologie und Allergologie, Philipps-Universität Marburg, Marburg, Deutschland.
French LE; Dermatologische Klinik, Universität Zürich, Zürich, Schweiz.
Girolomoni G; Abteilung für Dermatologie, Universität Verona, Verona, Italien.
Hertl M; Klinik für Dermatologie und Allergologie, Philipps-Universität Marburg, Marburg, Deutschland.
Jolles S; Immundefizienz-Zentrum für Wales, Universitätskrankenhaus Wales, Cardiff, Großbritannien.
Karpati S; Abteilung für Dermatologie, Semmelweis-Universität Budapest, Budapest, Ungarn.
Steinbrink K; Universitäts-Hautklinik, Johannes-Gutenberg-Universität Mainz, Mainz, Deutschland.
Stingl G; Universitätsklinik für Dermatologie, Medizinische Universität Wien, Wien, Österreich.
Volc-Platzer B; Universitätsklinik für Dermatologie, Medizinische Universität Wien, Wien, Österreich.
Zillikens D; Klinik für Dermatologie, Allergologie und Venerologie, Universität zu Lübeck, Lübeck, Deutschland.
Enk A; Hautklinik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland. .
Pokaż więcej
Transliterated Title :
Europäische Leitlinien (S1) für die Verwendung von hoch dosierten intravenösen Immunglobulinen in der Dermatologie.
Źródło :
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete [Hautarzt] 2020 Jul; Vol. 71 (7), pp. 542-552.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Practice Guidelines as Topic*
Autoimmune Diseases/*drug therapy
Dermatology/*standards
Immunoglobulins, Intravenous/*administration & dosage
Skin Diseases/*drug therapy
Autoimmune Diseases/diagnosis ; Dermatology/methods ; Dose-Response Relationship, Drug ; Europe ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Skin Diseases/diagnosis ; Stevens-Johnson Syndrome
Czasopismo naukowe
Tytuł :
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Autorzy :
Nguyen AA; Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
Habiballah SB; Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
Platt CD; Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
Geha RS; Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
Chou JS; Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
McDonald DR; Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2020 Jul; Vol. 216, pp. 108459. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Pandemics*
Betacoronavirus/*drug effects
Coronavirus Infections/*drug therapy
Cytokine Release Syndrome/*pathology
Immunoglobulins, Intravenous/*administration & dosage
Immunologic Factors/*administration & dosage
Pneumonia, Viral/*drug therapy
Adaptive Immunity/drug effects ; Angiotensin-Converting Enzyme 2 ; Antibody-Dependent Enhancement/drug effects ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Coronavirus Infections/therapy ; Coronavirus Infections/virology ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/immunology ; Cytokine Release Syndrome/prevention & control ; Gene Expression ; Humans ; Immunity, Innate/drug effects ; Immunization, Passive/adverse effects ; Immunization, Passive/methods ; Immunoglobulins, Intravenous/adverse effects ; Immunologic Factors/adverse effects ; Molecular Targeted Therapy ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/immunology ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; T-Lymphocytes/virology
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Is a second course of intravenous immunoglobulin treatment in Guillain-Barré syndrome justifiable?
Autorzy :
Yang J; Department of Anesthesiology, Central Hospital of Cangzhou, Xinhua Middle Street 201#, 061001 Cangzhou, Hebei Province, China.
Jia R; Department of Neurology, Central Hospital of Cangzhou, Xinhua Middle Street 201#, 061001 Cangzhou, Hebei Province, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2020 Jul; Vol. 77, pp. 251-252. Date of Electronic Publication: 2020 Apr 18.
Typ publikacji :
Letter; Comment
MeSH Terms :
Guillain-Barre Syndrome*
Immunoglobulins, Intravenous*
Administration, Intravenous ; Albumins ; Biomarkers ; Humans
Opinia redakcyjna
Tytuł :
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning.
Autorzy :
Shoenfeld Y; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Tel-Aviv University, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russian Federation. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2020 Jun; Vol. 19 (6), pp. 102538. Date of Electronic Publication: 2020 Apr 05.
Typ publikacji :
Editorial
MeSH Terms :
Betacoronavirus/*pathogenicity
Coronavirus Infections/*diagnosis
Coronavirus Infections/*therapy
Ferritins/*blood
Immunoglobulins, Intravenous/*therapeutic use
Interleukin-1/*antagonists & inhibitors
Interleukin-6/*antagonists & inhibitors
Pneumonia, Viral/*diagnosis
Pneumonia, Viral/*therapy
Viral Vaccines/*immunology
Aged, 80 and over ; Antigens, CD/blood ; Antigens, Differentiation, Myelomonocytic/blood ; Antiphospholipid Syndrome ; Betacoronavirus/immunology ; Biomarkers/blood ; CD28 Antigens/antagonists & inhibitors ; COVID-19 ; COVID-19 Vaccines ; Coronavirus Infections/blood ; Coronavirus Infections/immunology ; Coronavirus Infections/prevention & control ; Humans ; Immunization, Passive ; Immunoglobulins, Intravenous/administration & dosage ; Macrophage Activation Syndrome ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/immunology ; Receptors, Cell Surface/blood ; Respiratory Insufficiency/blood ; Respiratory Insufficiency/complications ; SARS-CoV-2 ; Shock, Septic ; Viral Vaccines/adverse effects
SCR Protocol :
COVID-19 serotherapy
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies